Researcher Profile

Researcher Profile

Qiushi Chen

Qiushi Chen

Assistant Professor, Marcus Department of Industrial and Manufacturing Engineering
Scientific Program:Cancer Control
qxc35@psu.edu

Research Interests

  • Therapeutics
  • Cost-Benefit Analysis
  • Costs and Cost Analysis
  • Hepatitis C
  • Hepacivirus
  • Quality-Adjusted Life Years
  • Antiviral Agents
  • Colorectal Neoplasms
  • Lymphoma, Large B-Cell, Diffuse
  • Drug Therapy
  • Population
  • Rituximab

Recent Publications

2020

Zhuo, Y, Hayashi, T, Chen, Q, Aggarwal, R, Hutin, Y & Chhatwal, J 2020, 'Estimating the price at which hepatitis C treatment with direct-acting antivirals would be cost-saving in Japan', Scientific reports, vol. 10, no. 1, 4089. https://doi.org/10.1038/s41598-020-60986-4

2019

Çağlayan, Ç, Terawaki, H, Ayer, T, Goldstein, JS, Rai, A, Chen, Q & Flowers, C 2019, 'Assessing the Effectiveness of Treatment Sequences for Older Patients With High-risk Follicular Lymphoma With a Multistate Model', Clinical Lymphoma, Myeloma and Leukemia, vol. 19, no. 5, pp. 300-309.e5. https://doi.org/10.1016/j.clml.2018.12.019
Chhatwal, J, Chen, Q, Wang, X, Ayer, T, Zhuo, Y, Janjua, NZ & Kanwal, F 2019, 'Assessment of the Feasibility and Cost of Hepatitis C Elimination in Pakistan', JAMA network open, vol. 2, no. 5, pp. e193613. https://doi.org/10.1001/jamanetworkopen.2019.3613
Chen, Q, Ayer, T, Bethea, E, Kanwal, F, Wang, X, Roberts, M, Zhuo, Y, Fagiuoli, S, Petersen, J & Chhatwal, J 2019, 'Changes in hepatitis C burden and treatment trends in Europe during the era of direct-acting antivirals: A modelling study', BMJ open, vol. 9, no. 6, e026726. https://doi.org/10.1136/bmjopen-2018-026726
Chen, Q, Larochelle, MR, Weaver, DT, Lietz, AP, Mueller, PP, Mercaldo, S, Wakeman, SE, Freedberg, KA, Raphel, TJ, Knudsen, AB, Pandharipande, PV & Chhatwal, J 2019, 'Prevention of Prescription Opioid Misuse and Projected Overdose Deaths in the United States', JAMA network open, vol. 2, no. 2, pp. e187621. https://doi.org/10.1001/jamanetworkopen.2018.7621
Chhatwal, J, Chen, Q, Bethea, ED, Hur, C, Spaulding, AC & Kanwal, F 2019, 'The impact of direct-acting anti-virals on the hepatitis C care cascade: identifying progress and gaps towards hepatitis C elimination in the United States', Alimentary Pharmacology and Therapeutics, vol. 50, no. 1, pp. 66-74. https://doi.org/10.1111/apt.15291

2018

Goel, A, Chen, Q, Chhatwal, J & Aggarwal, R 2018, 'Cost-effectiveness of generic pan-genotypic sofosbuvir/velpatasvir versus genotype-dependent direct-acting antivirals for hepatitis C treatment', Journal of Gastroenterology and Hepatology (Australia), vol. 33, no. 12, pp. 2029-2036. https://doi.org/10.1111/jgh.14301
Chen, Q, Zhao, L, Fransoo, JC & Li, Z 2019, 'Dual-mode inventory management under a chance credit constraint', OR Spectrum, vol. 41, no. 1, pp. 147-178. https://doi.org/10.1007/s00291-018-0532-4
Chhatwal, J, Chen, Q & Aggarwal, R 2018, 'Estimation of Hepatitis C Disease Burden and Budget Impact of Treatment Using Health Economic Modeling', Infectious Disease Clinics of North America, vol. 32, no. 2, pp. 461-480. https://doi.org/10.1016/j.idc.2018.02.008
Chen, Q, Staton, AD, Ayer, T, Goldstein, DA, Koff, JL & Flowers, CR 2018, 'Exploring the potential cost-effectiveness of precision medicine treatment strategies for diffuse large B-cell lymphoma', Leukemia and Lymphoma, vol. 59, no. 7, pp. 1700-1709. https://doi.org/10.1080/10428194.2017.1390230
Chhatwal, J, Chen, Q, Bethea, ED, Ladd, MA, Mueller, PP, Hutin, Y & Aggarwal, R 2018, 'Hep C Calculator: an online tool for cost-effectiveness analysis of DAAs', The Lancet Gastroenterology and Hepatology, vol. 3, no. 12. https://doi.org/10.1016/S2468-1253(18)30281-4
Chhatwal, J, Chen, Q, Ayer, T, Bethea, ED, Kanwal, F, Kowdley, KV, Wang, X, Roberts, MS & Gordon, SC 2018, 'Hepatitis C virus re-treatment in the era of direct-acting antivirals: projections in the USA', Alimentary Pharmacology and Therapeutics, vol. 47, no. 7, pp. 1023-1031. https://doi.org/10.1111/apt.14527
Çağlayan, Ç, Terawaki, H, Chen, Q, Rai, A, Ayer, T & Flowers, CR 2018, 'Microsimulation modeling in oncology', JCO Clinical Cancer Informatics, vol. 2018, no. 2, pp. 1-11. https://doi.org/10.1200/CCI.17.00029
Chen, Q, Ayer, T & Chhatwal, J 2018, 'Optimal M-switch surveillance policies for liver cancer in a hepatitis C-infected population', Operations Research, vol. 66, no. 3, pp. 673-696. https://doi.org/10.1287/opre.2017.1706
Bethea, ED, Chen, Q, Hur, C, Chung, RT & Chhatwal, J 2018, 'Reply', Hepatology, vol. 67, no. 4, pp. 1641-1642. https://doi.org/10.1002/hep.29770
Bethea, ED, Chen, Q, Hur, C, Chung, RT & Chhatwal, J 2018, 'Should we treat acute hepatitis C? A decision and cost-effectiveness analysis', Hepatology, vol. 67, no. 3, pp. 837-846. https://doi.org/10.1002/hep.29611

2017

Goldstein, DA, Chen, Q, Ayer, T, Chan, KKW, Virik, K, Hammerman, A, Brenner, B, Flowers, CR & Hall, PS 2017, 'Bevacizumab for metastatic colorectal cancer: A global cost-effectiveness analysis', Oncologist, vol. 22, no. 6, pp. 694-699. https://doi.org/10.1634/theoncologist.2016-0455
Aggarwal, R, Chen, Q, Goel, A, Seguy, N, Pendse, R, Ayer, T & Chhatwal, J 2017, 'Cost-effectiveness of hepatitis C treatment using generic direct-acting antivirals available in India', PloS one, vol. 12, no. 5, e0176503. https://doi.org/10.1371/journal.pone.0176503
Kohn, CG, Zeichner, SB, Chen, Q, Montero, AJ, Goldstein, DA & Flowers, CR 2017, 'Cost-effectiveness of immune checkpoint inhibition in BRAF wild-type advanced melanoma', Journal of Clinical Oncology, vol. 35, no. 11, pp. 1194-1202. https://doi.org/10.1200/JCO.2016.69.6336
Chen, Q, Jain, N, Ayer, T, Wierda, WG, Flowers, CR, O'Brien, SM, Keating, MJ, Kantarjian, HM & Chhatwal, J 2017, 'Economic burden of chronic lymphocytic leukemia in the era of oral targeted therapies in the United States', Journal of Clinical Oncology, vol. 35, no. 2, pp. 166-174. https://doi.org/10.1200/JCO.2016.68.2856
Chen, Q, Jain, N, Flowers, CR & Chhatwal, J 2017, 'Reply to C. Nabhan et al', Journal of Clinical Oncology, vol. 35, no. 16, pp. 1864-1865. https://doi.org/10.1200/JCO.2017.72.2769
Kohn, CG, Zeichner, SB, Chen, Q, Montero, AJ, Flowers, CR & Goldstein, DA 2017, 'Reply to Á. Benedict et al', Journal of Clinical Oncology, vol. 35, no. 26, pp. 3086-3087. https://doi.org/10.1200/JCO.2017.74.5273

2016

Chen, Q, Ayer, T, Nastoupil, LJ, Koff, JL, Staton, AD, Chhatwal, J & Flowers, CR 2016, 'Population-specific prognostic models are needed to stratify outcomes for African-Americans with diffuse large B-cell lymphoma', Leukemia and Lymphoma, vol. 57, no. 4, pp. 842-851. https://doi.org/10.3109/10428194.2015.1083098
Chen, Q, Ayer, T & Chhatwal, J 2016, 'Sensitivity Analysis in Sequential Decision Models', Medical Decision Making, vol. 37, no. 2, pp. 243-252. https://doi.org/10.1177/0272989X16670605

Clinical Trials Search


Children (age < 18 years)
Adults (age >= 18 years)